Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23925)

Formulation Name
Tucatinib 150 mg tablet
Company
Seattle Genetics
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Tucatinib DMBESUA HER2-positive breast cancer 2C60-2C65 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Cellulose microcrystalline E00698 Not Available Adsorbent; Suspending agent; Diluent
Copovidone E00693 Not Available Film/membrane-forming agent; Modified-release agent; Binding agent
Crospovidone E00626 Not Available Disintegrant
Ferric hydroxide oxide yellow E00539 23320441 Colorant
Hydrophobic colloidal silica E00285 24261 Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Magnesium stearate E00208 11177 lubricant
Polyethylene glycol 4000 E00654 Not Available Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polyvinyl alcohol E00666 Not Available Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Potassium chloride E00074 4873 Tonicity agent
Sodium bicarbonate E00424 516892 Alkalizing agent; Diluent
Sodium chloride E00077 5234 Diluent; Tonicity agent
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent